CN105658221B - 用于治疗萎缩性皮肤瘢痕形成的前列腺素F2α及其类似物 - Google Patents

用于治疗萎缩性皮肤瘢痕形成的前列腺素F2α及其类似物 Download PDF

Info

Publication number
CN105658221B
CN105658221B CN201480053306.1A CN201480053306A CN105658221B CN 105658221 B CN105658221 B CN 105658221B CN 201480053306 A CN201480053306 A CN 201480053306A CN 105658221 B CN105658221 B CN 105658221B
Authority
CN
China
Prior art keywords
pharmaceutical composition
atrophic
skin
scarring
analog
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201480053306.1A
Other languages
English (en)
Chinese (zh)
Other versions
CN105658221A (zh
Inventor
沃伦·J·舍雷尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galderma SA
Original Assignee
Galderma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma SA filed Critical Galderma SA
Publication of CN105658221A publication Critical patent/CN105658221A/zh
Application granted granted Critical
Publication of CN105658221B publication Critical patent/CN105658221B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Dispersion Chemistry (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • External Artificial Organs (AREA)
CN201480053306.1A 2013-09-26 2014-09-26 用于治疗萎缩性皮肤瘢痕形成的前列腺素F2α及其类似物 Expired - Fee Related CN105658221B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361960740P 2013-09-26 2013-09-26
US61/960,740 2013-09-26
PCT/IB2014/002746 WO2015044788A1 (en) 2013-09-26 2014-09-26 Prostaglandin f2alpha and analogues thereof for treating atrophic cutaneous scarring

Publications (2)

Publication Number Publication Date
CN105658221A CN105658221A (zh) 2016-06-08
CN105658221B true CN105658221B (zh) 2022-05-10

Family

ID=52282772

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201480053306.1A Expired - Fee Related CN105658221B (zh) 2013-09-26 2014-09-26 用于治疗萎缩性皮肤瘢痕形成的前列腺素F2α及其类似物

Country Status (11)

Country Link
US (1) US10039770B2 (enExample)
EP (1) EP3049088B1 (enExample)
JP (1) JP6453318B2 (enExample)
KR (1) KR102221499B1 (enExample)
CN (1) CN105658221B (enExample)
AU (1) AU2014326298B2 (enExample)
BR (1) BR112016006426A2 (enExample)
CA (1) CA2924460A1 (enExample)
MX (1) MX374476B (enExample)
RU (1) RU2690183C2 (enExample)
WO (1) WO2015044788A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3319607A4 (en) * 2015-07-09 2019-04-03 Galderma S.A. METHOD FOR REDUCING HAIR LOSS IN CONNECTION WITH CHEMOTHERAPY
CN106929477B (zh) * 2017-03-20 2020-01-10 江南大学 一株抗前列腺素F2α的特异性单克隆抗体杂交瘤细胞株WXX-2及其应用
KR20240004954A (ko) * 2021-05-07 2024-01-11 바치바이오메드 인크. 소분자 화합물을 사용하여 여드름-후 위축성 흉터의 외관을 개선하는 방법 (methods of using a small molecule chemical compound to reduce the appearance of post-acne atrophic scarring)

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3278447A (en) 1963-12-02 1966-10-11 Cloro Bac Products Inc Process for stabilizing chlorine dioxide solution
CA2003198C (en) 1988-11-29 1995-03-21 Anthony J. Dziabo, Jr. Aqueous ophthalmic solutions and method for preserving same
US5736165A (en) 1993-05-25 1998-04-07 Allergan In-the-eye use of chlorine dioxide-containing compositions
US6194415B1 (en) 1995-06-28 2001-02-27 Allergan Sales, Inc. Method of using (2-imidazolin-2-ylamino) quinoxoalines in treating neural injury
RU2195889C2 (ru) * 1999-05-24 2003-01-10 Парамонов Борис Алексеевич Способ дермабразии
US6468989B1 (en) 2000-07-13 2002-10-22 Dow Pharmaceutical Sciences Gel compositions containing metronidazole
US6387383B1 (en) 2000-08-03 2002-05-14 Dow Pharmaceutical Sciences Topical low-viscosity gel composition
US7405274B2 (en) * 2003-06-04 2008-07-29 Fibrogen, Inc. Connective tissue growth factor antibodies
AU2009246333B2 (en) * 2008-05-16 2013-05-09 Corthera, Inc. Method of promoting wound healing
EP2389939A1 (en) * 2010-05-28 2011-11-30 Novagali Pharma S.A. Use of prostaglandins F2alpha and analogues for the healing of corneal and conjunctival lesions
CN102031260A (zh) * 2010-08-24 2011-04-27 苏州圣诺生物医药技术有限公司 促进皮肤伤口无疤痕愈合的siRNA及应用
JP2014500275A (ja) * 2010-12-06 2014-01-09 フォリカ，インコーポレイテッド 禿頭症を治療するため、および毛髪の成長を促進するための方法
BR112013019519A2 (pt) * 2011-01-31 2016-08-09 Allergan Inc método de realce de crescimento capilar
US20120251613A1 (en) * 2011-03-29 2012-10-04 Agila Specialities Pvt. Ltd. Method for treating vitiligo with a prostaglandin analogue
WO2014179263A1 (en) * 2013-04-30 2014-11-06 Allergan, Inc. Therapeutic agents

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Repigmentation of Hypopigmented Scars Using an Erbium-Doped 1,550-nm Fractionated Laser and Topical Bimatoprost;ANE BEATRIZ MAUTARI NIWA MASSAKI等;《DERMATOLOGIC SURGERY》;20121231;第38卷;第995–1001页 *

Also Published As

Publication number Publication date
US10039770B2 (en) 2018-08-07
AU2014326298A1 (en) 2016-04-07
RU2690183C2 (ru) 2019-05-31
RU2016110925A3 (enExample) 2018-07-13
EP3049088B1 (en) 2021-02-17
BR112016006426A2 (pt) 2017-08-01
CA2924460A1 (en) 2015-04-02
EP3049088A1 (en) 2016-08-03
KR20160055941A (ko) 2016-05-18
AU2014326298B2 (en) 2019-07-04
JP6453318B2 (ja) 2019-01-16
US20160228453A1 (en) 2016-08-11
JP2016531872A (ja) 2016-10-13
MX374476B (es) 2025-03-06
MX2016003650A (es) 2016-06-24
RU2016110925A (ru) 2017-11-01
KR102221499B1 (ko) 2021-03-02
WO2015044788A1 (en) 2015-04-02
CN105658221A (zh) 2016-06-08

Similar Documents

Publication Publication Date Title
CN101902913B (zh) 手术前处理
KR101420599B1 (ko) 항여드름제를 함유하는 조성물 및 이의 용도
US20020054896A1 (en) Method and composition for the treatment of scars
RU2587041C2 (ru) Способ предотвращения или лечения опухоли кожи
JP7421558B2 (ja) 組織修復に適用されるピルフェニドンを含有する半固体油性医薬組成物
US20200012989A1 (en) Compositions and methods for treating cutaneous conditions
JP2024144774A (ja) 化粧品／皮膚科用組成物
HK1220637A1 (zh) 治疗皮肤增厚的方法
JP2015530380A (ja) 乾癬を治療するための組成物
JP6453318B2 (ja) 委縮性皮膚瘢痕を治療するためのプロスタグランジンＦ２α及びその類似体
JP2014518239A (ja) 皮膚反応を低減するための新規な安定麻酔組成物
EP2994120B1 (en) Alpha adrenergic agonists for the treatment of tissue trauma
JP2014530847A (ja) 毛細血管腫の治療方法
US20190000936A1 (en) Prophylactic normalization of cutaneous wound repair
US20170281690A1 (en) Pharmaceutical composition for preventing, treating and curing rosacea, comprising snail slime, chamomile and propolis
KR101917026B1 (ko) 피부 주름 개선 또는 예방용 화장료 조성물
CN117651553A (zh) 用于治疗萎缩性瘢痕的犬尿氨酸及其衍生物
DE202018000489U1 (de) Hautpflegeprodukt zur Behandlung frischer und alter Narben

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20220510

CF01 Termination of patent right due to non-payment of annual fee